1. Home
  2. LOB vs IOVA Comparison

LOB vs IOVA Comparison

Compare LOB & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

HOLD

Current Price

$43.45

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$6.89

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOB
IOVA
Founded
2008
2007
Country
United States
United States
Employees
1040
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
LOB
IOVA
Price
$43.45
$6.89
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$43.00
$9.00
AVG Volume (30 Days)
206.4K
18.1M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
0.32%
N/A
EPS Growth
31.95
14.84
EPS
1.35
N/A
Revenue
N/A
N/A
Revenue This Year
$35.52
$47.74
Revenue Next Year
$16.03
$40.31
P/E Ratio
$32.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.36
$1.76
52 Week High
$44.53
$6.92

Technical Indicators

Market Signals
Indicator
LOB
IOVA
Relative Strength Index (RSI) 57.75 71.21
Support Level $39.86 $3.57
Resistance Level $44.19 $6.92
Average True Range (ATR) 1.01 0.43
MACD -0.09 0.18
Stochastic Oscillator 58.36 93.75

Price Performance

Historical Comparison
LOB
IOVA

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: